Understanding the mechanism(s) by which HLA-B*57:01 benefits control of viral infections, whether through TCR-mediated activation of T cells or by tuning of HLA-KIR interactions, is of medical importance. The gene discussed is KIR3DL1; the disease is viral infectious disease.